glp 1 for chronic kidney disease Frontiers Design and discovery of a
Description
It also helps avoid constipation, one of the most common side effects of GLP-1s
(2020) also compared newly diagnosed diabetic cats that received insulin glargine alone or with long-acting exenatide (weekly application of 200 g.kg 1 for 16 weeks)
10.1016/j.mvr.2018.07.005 30
Research published in the Journal of the American Medical Association found that GLP-1 drug users faced a higher risk of gastroparesis compared to users of other weight loss medications or diabetes drugs
J Diabetes its Complications (2017) 31(9):13705
doi: 10.1111/bjd.12886 42 MoensEVeldhoenM
